elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Caspase 1
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Caspase 1
RIS
0.001
(Research Intensity Score)
Papers
80
Top papers
Copper metabolism in cell death and autophagy
2023 · 693 citations
Mitochondria ROS and mitophagy in acute kidney injury
2022 · 788 citations
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 · 3478 citations
ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation
2023 · 135 citations
Loop Between NLRP3 Inflammasome and Reactive Oxygen Species
2021 · 226 citations
Newest papers
Delaying Stress Granule Disassembly by PARG Inhibition Attenuates Renal Tubular Cell Pyroptosis in Acute Kidney Injury
2026
The Cytopathogenic BVDV Core Protein Binds with ASC-Enhance the Assembly of Inflammasome Complex and GSDMD-Mediated Pyroptosis
2026
O-GlcNAc Modification of CEBPB Promotes Astrocytic Pyroptosis by Activating NLRP3 Inflammasome Through Transcriptional Activation of IKKβ
2026
ALDH2 deficiency in pancreatic acinar cells aggravates acute pancreatitis by promoting NLRP3 inflammasome activation through autophagy
2026
Self‐Enhancing Drug Pair‐Driven Selenium Nanotherapeutics Reverses Microglial Pyroptosis Through NLRP3/Caspase‐1 Pathway and Neuronal Apoptosis for Treatment of Spinal Cord Injury
2025 · 9 citations
A sample from the 80 top papers behind Caspase 1.
Create a free account to browse them all →
Caspase 1's history
Research intensity over time
Explore Caspase 1's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Caspase 1's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link